Switch from enfuvirtide (ENF) to raltegravir (RAL): a simplification option for heavily pretreated HIV patients (pts)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-2652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Switch from enfuvirtide (ENF) to raltegravir (RAL): a simplification option for heavily pretreated HIV patients (pts) ; volume:11 ; number:1 ; day:10 ; month:11 ; year:2008 ; pages:1-2 ; date:12.2008
Journal of the International AIDS Society / International AIDS Society ; 11, Heft 1 (10.11.2008), 1-2, 12.2008
- Creator
-
Gatti, F.
- Contributor
-
Matti, A.
Nasta, P.
Cologni, G.
Costarelli, S.
Carosi, G.
SpringerLink (Online service)
- DOI
-
10.1186/1758-2652-11-S1-P52
- URN
-
urn:nbn:de:1111-2016052054828
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gatti, F.
- Matti, A.
- Nasta, P.
- Cologni, G.
- Costarelli, S.
- Carosi, G.
- SpringerLink (Online service)
Other Objects (12)
Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report
Therapeutic options in heavily pretreated HIV-1 patients based on the genotypic resistance patterns
PTS
PTS
Simplification
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
SPAIce PTS
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report
Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report
Therapeutic options in heavily pretreated HIV-1 patients based on the genotypic resistance patterns
PTS
PTS
Simplification
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
SPAIce PTS
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report
Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report
Therapeutic options in heavily pretreated HIV-1 patients based on the genotypic resistance patterns
PTS
PTS
Simplification
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
SPAIce PTS
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report